“Inspiratory muscle training (IMT) has been applied during pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD). However, it remains unclear if the addition of IMT to a general exercise training programme leads to additional clinically relevant improvements in patients with COPD.
This randomised controlled trial will investigate whether the addition of IMT to a general exercise training programme improves 6 min walking distance, health-related quality of life, daily physical activity and inspiratory muscle function in patients with COPD with inspiratory muscle weakness.”
Go to Inspiratory muscle training protocol for patients with chronic obstructive pulmonary disease (IMTCO study): a multicentre randomised controlled trial >
Inspiratory muscle training protocol for patients with chronic obstructive pulmonary disease (IMTCO study): a multicentre randomised controlled trial
Noppawan Charususin, Rik Gosselink, Marc Decramer, et al
Published 5 August 2013
The latest paper on the Inspiratory Muscle Training Protocol for Patients with COPD (IMTCO) study design has just been published in Respiratory Medicine on BMJ Open. This study used the POWERbreathe KH1 for home-based IMT. It is suggested that the results of the study could be incorporated into evidence-based treatment recommendations for clinical practice. ClinicalTrials.gov NCT01397396.
Aims of the study:
“This study will examine the effects of adding a well-controlled, high-intensity IMT programme to a 3-month general exercise training programme, using a large, multicentre, randomised controlled design, in patients with COPD and inspiratory muscle weakness. Outcomes will be exercise capacity (primary outcome), inspiratory muscle function, health-related quality of life (HRQL) and participation in daily physical activity.”
Read the full Open Access article online.